Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac

Farhat Nasim9 May 2025 7:51 PM IST

Empagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.

CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions

NPPA Slashes Retail Price of Vitamin D3 Oral Solutions Marketed by Aristo, Macleods

Farhat Nasim8 May 2025 8:25 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has corrected and reduced the retail prices of Cholecalciferol (Vitamin D3) oral...

NMC Yet To Take Action Against 30 Doctors Named in Rs 1.91 Cr Freebie Case- RTI Response

Farhat Nasim8 May 2025 9:30 AM IST

New Delhi: Months after the Apex Committee for Pharma Marketing Practices (ACPMP) under the Department of Pharmaceuticals (DoP) reprimanded AbbVie...

Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist

Farhat Nasim7 May 2025 7:41 PM IST

New Delhi: Reckitt Benckiser, the company behind Dettol, has informed the Delhi High Court that it has reached a settlement with popular social media...

Ranitidine Under Scanner Again: DTAB, CDSCO Recommends New Safety Study, Tighter Monitoring

Ranitidine Under Scanner Again: DTAB, CDSCO Recommend New Safety Study, Tighter Monitoring

Farhat Nasim6 May 2025 6:02 PM IST

New Delhi: Amid continued global concerns over the presence of N-nitrosodimethylamine (NDMA) impurities in ranitidine, the Drugs Technical Advisory...

Substandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation

Farhat Nasim5 May 2025 5:16 PM IST

New Delhi: In a significant move to tighten quality control and safeguard public health, the Drugs Technical Advisory Board (DTAB) has recommended...

Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions

Farhat Nasim3 May 2025 7:31 PM IST

New Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...

'Ghatiya' Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers' Criticism of Protein Supplement

Farhat Nasim1 May 2025 7:41 PM IST

New Delhi: In a significant ruling defining the boundaries of free speech and online criticism in the digital age, the Delhi High Court has refused to...

Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination

Farhat Nasim1 May 2025 7:01 PM IST

New Delhi: In a significant development in the ongoing corporate controversy at Medikabazaar, the Delhi High Court has admitted a petition filed...

Govt Issues Export Guidelines for Doxycycline 100 mg Dispersible Tablets

Farhat Nasim30 April 2025 7:29 PM IST

New Delhi: The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03/2025-26 dated...

Minor Drug Law Violations Can Now Be Settled Without Trial: Health Ministry Issues Rules

Farhat Nasim28 April 2025 7:21 PM IST

New Delhi: The Ministry of Health and Family Welfare has notified the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, allowing...

Delhi HC grants relief to 28 BAMS students, directs centre to grant recognition to S.S. Ayurveda Medical College

Cough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus

Farhat Nasim26 April 2025 7:09 PM IST

New Delhi: In a major relief to pharma companies Glenmark Pharmaceuticals Ltd. and Zuventus Healthcare Ltd., the Delhi High Court has ruled that the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok